Clinical Trials Arena on MSN6d
Roche’s discontinued Alzheimer’s drug shows signs of preventing onsetInvestigators said that the OLE study showed Roche’s gantenerumab dropped the risk of developing symptoms by 50%.
This article delves into the theoretical roles of these peptides in brain research and discusses the directions in which they ...
One such assembly, amyloid beta peptide, is synonymous with dementia, but researchers were not certain how these peptide assemblies "break bad" and what really causes them to assemble. Now ...
They are also thought to be much more toxic to neurons than other amyloid-beta peptides. The Lilly data is from a phase I trial, so will be aimed mainly at showing the safety of LY3002813 at ...
PsyPost on MSN1mon
Stalled protein processing may underlie Alzheimer’s diseaseThese mutations are found in the genes that encode the enzyme and substrate that produce the amyloid beta-peptide, so there ...
Amyloid β protein (Aβ ... Primary rat cortical cultures (500 cells per mm 2) were incubated with the indicated peptide for 18 h at 37°C. At this cell density, neurotoxicity from fibrillar ...
A new study published in the journal of Clinical and Experimental Dermatology showed that for non-nodular primary localized cutaneous amyloidosis (PLCA), laser therapy is recommended, but ...
Background Patients with transthyretin amyloid cardiomyopathy (ATTR-CM) often experience worsening cardiac disease (WCD) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback